Literature DB >> 92576

Establishment of a C3Hf mammary tumor cell line expressing endogenous mouse mammary tumor virus: antigenic and genetic relationships of this virus with highly oncogenic mouse mammary tumor viruses.

L O Arthur, G G Lovinger, G Schochetman.   

Abstract

A single-cell clone of C3Hf mammary tumor cells (clone 14) was developed into a continuous cell line expressing high levels of endogenous mouse mammary tumor virus (MMTV) with less than 0.1% murine leukemia virus expression. Comparison of the C3Hf MMTV protein profile on sodium dodecyl sulfatepolyacrylamide gel electrophoresis with that of C3H MMTV revealed that the protein content of the two viruses was quite similar. However, oligonucleotide fingerprints obtained of MMTV 70S RNA revealed that approximately 20% of the large oligonucleotides examined were unique to each virus. The oligonucleotide fingerprint indicated that although the viruses were similar, they differed in their genetic content. The differences in the two viruses extended to immunological differences in the major envelope glycoprotein, gp52. C3Hf MMTV competed only partially in a homologous radioimmunoassay for gp52 of C3H MMTV, whereas C3H MMTV gave complete competition, indicating that gp52 of C3H MMTV contained type-specific determinants not present on gp52 of C3Hf MMTV. Comparison of C3Hf MMTV with highly oncogenic C3H, GR, and RIII MMTVs in a homologous C3H MMTV gp52 assay gave two patterns of reactivity: complete competition by GR and C3H MMTV and incomplete competition by C3Hf and RIII MMTV. Absorption of anti-C3H MMTV serum by either C3Hf MMTV or RIII MMTV removed all antibodies against both viruses but not against GR and C3H MMTVs. These results indicate that C3H and GR MMTVs are more closely related to each other than to RIII and C3Hf MMTVs.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 92576      PMCID: PMC525934     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Viruslike particles in precancerous hyperplastic mammary tissues of C3H and C3Hf mice.

Authors:  D R PITELKA; K B DEOME; H A BERN
Journal:  J Natl Cancer Inst       Date:  1960-10       Impact factor: 13.506

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Factors in the development of spontaneous mammary gland tumors in agent--free strain C3Hb mice.

Authors:  W E HESTON; M K DERINGER; T B DUNN; W D LEVILLAIN
Journal:  J Natl Cancer Inst       Date:  1950-04       Impact factor: 13.506

4.  Oncogenicity of murine mammary tumor virus produced in tissue culture: brief communication.

Authors:  L O Arthur; D L Fine; P Bentvelzen
Journal:  J Natl Cancer Inst       Date:  1978-02       Impact factor: 13.506

5.  Biochemical evidence that MCF murine leukemia viruses are envelope (env) gene recombinants.

Authors:  J H Elder; J W Gautsch; F C Jensen; R A Lerner; J W Hartley; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

6.  Studies of genetic transmission of mammary tumour virus by C3Hf mice.

Authors:  R van Nie; A A Verstraeten
Journal:  Int J Cancer       Date:  1975-12-15       Impact factor: 7.396

7.  Bioactivity of C3H and RIII mammary tumor viruses in virgin female BALB/c mice.

Authors:  F Squartini; M Bistocchi
Journal:  J Natl Cancer Inst       Date:  1977-06       Impact factor: 13.506

8.  Differences in mouse mammary tumor viruses. Relationship to early and late occurring mammary tumors.

Authors:  J Schlom; D Colcher; W Drohan; R Kettmann; R Michalides; G Vlahakis; J Young
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

9.  Biologic characteristics of some mouse mammary tumor viruses.

Authors:  D H Moore; J A Holben; J Charney
Journal:  J Natl Cancer Inst       Date:  1976-10       Impact factor: 13.506

10.  A biochemical approach to the study of the transmission of mouse mammary tumor viruses in mouse strains RIII and C3H.

Authors:  R Michalides; G Vlahakis; J Schlom
Journal:  Int J Cancer       Date:  1976-07-15       Impact factor: 7.396

View more
  7 in total

1.  Conservation of protein coding potential in the long terminal repeats of exogenous and endogenous mouse mammary tumor viruses.

Authors:  G Peters; R Smith; S Brookes; C Dickson
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

2.  Increased yield of mouse mammary tumor virus (MMTV) by cultivation of monolayer-derived mammary tumor cells in suspension.

Authors:  F Maldarelli; M J Yagi
Journal:  In Vitro Cell Dev Biol       Date:  1986-09

3.  Immunological characterization of a low oncogenic mouse mammary tumor virus BALB/cNIV mice.

Authors:  J P Vacquier; R D Cardiff; P B Blair
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

4.  Processing and amino acid sequence analysis of the mouse mammary tumor virus env gene product.

Authors:  L O Arthur; T D Copeland; S Oroszlan; G Schochetman
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

5.  Monoclonal antibodies identify individual determinants on mouse mammary tumor virus glycoprotein gp52 with group, class, or type specificity.

Authors:  R J Massey; L O Arthur; R C Nowinski; G Schochetman
Journal:  J Virol       Date:  1980-06       Impact factor: 5.103

6.  C3H/HeN mammary tumor-bearing mice develop type-specific neutralizing antibodies and group-specific precipitating antibodies for the mouse mammary tumor virus.

Authors:  R Massey; L O Arthur; C W Long; G Schochetman
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

7.  Late developing mammary tumors and hyperplasia induced by a low-oncogenic variant of mouse mammary tumor virus (MMTV) express genes identical to those induced by canonical MMTV.

Authors:  Robert D Bruno; Sonia M Rosenfield; Gilbert H Smith
Journal:  Mol Cancer       Date:  2013-07-18       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.